Generic lenacapavir
The FDA gave tentative approval to make a generic version of a groundbreaking HIV prevention medicine, a key step in widening access for dozens of low- and middle-income countries. https://www.statnews.com/pharmalot/2026/11/02/lenacapavir-generic-version-approved-fda-hiv-prevention-dr-reddys/
FDA OKs generic HIV prevention shot, widening access for lower-income countries
The FDA has approved a generic HIV prevention shot, a key step in widening access for dozens of lower-income countries.
www.statnews.com
November 2, 2026 at 5:55 PM
Generic lenacapavir
Mexico approved lenacapavir for HIV prevention: a PrEP shot given every six months instead of a daily pill. COFEPRIS authorized it on Sept 24, 2026, after the PURPOSE 1 and 2 trials showed very high effectiveness. It still requires medical evaluation and regular HIV testing. Source: COFEPRIS
October 31, 2026 at 1:30 AM
Mexico approved lenacapavir for HIV prevention: a PrEP shot given every six months instead of a daily pill. COFEPRIS authorized it on Sept 24, 2026, after the PURPOSE 1 and 2 trials showed very high effectiveness. It still requires medical evaluation and regular HIV testing. Source: COFEPRIS
Die US-amerikanische Medikamentenbehörde FDA hat das erste Generikum des Wirkstoffs #Lenacapavir zur medikamentösen #HIV- Prophylaxe #PrEP zugelassen. Das Präparat wird 2 x jährlich per Depotspritze gegeben und schützt zuverlässig vor einer Infektion. Verkauft werden darf es aber nur in 120 Ländern.
FDA Approves First Generic Of HIV Prevention Drug, Lenacapavir - Health Policy Watch
The US Food and Drug Administration (FDA) has approved the first generic version of lenacapavir, the highly effective twice-yearly injection to prevent HIV,
healthpolicy-watch.news
November 2, 2026 at 3:49 PM
Die US-amerikanische Medikamentenbehörde FDA hat das erste Generikum des Wirkstoffs #Lenacapavir zur medikamentösen #HIV- Prophylaxe #PrEP zugelassen. Das Präparat wird 2 x jährlich per Depotspritze gegeben und schützt zuverlässig vor einer Infektion. Verkauft werden darf es aber nur in 120 Ländern.
L’agence américaine du médicament approuve une version générique du traitement préventif contre le VIH #lenacapavir, présenté comme révolutionnaire.
Le fabricant indien, qui le vendra seulement 40 $ par personne et par an dans 120 pays, salue "un moment d’immense fierté".
1/2
Le fabricant indien, qui le vendra seulement 40 $ par personne et par an dans 120 pays, salue "un moment d’immense fierté".
1/2
November 2, 2026 at 5:47 PM
L’agence américaine du médicament approuve une version générique du traitement préventif contre le VIH #lenacapavir, présenté comme révolutionnaire.
Le fabricant indien, qui le vendra seulement 40 $ par personne et par an dans 120 pays, salue "un moment d’immense fierté".
1/2
Le fabricant indien, qui le vendra seulement 40 $ par personne et par an dans 120 pays, salue "un moment d’immense fierté".
1/2
US approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending Aids
US approves cheap generic version of world’s only twice-yearly HIV prevention jab
The Lenacapavir injection will cost just $40 a year in 120 countries, in what is seen as a major step towards ending Aids
trib.al
November 2, 2026 at 4:15 PM
US approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending Aids
It's the last weekend for you to sign our petition.
Lenacapavir would be a game-changer for those who don't have another PrEP option.
Sign the petition now.
https://tht.org.uk/prep-petition
Lenacapavir would be a game-changer for those who don't have another PrEP option.
Sign the petition now.
https://tht.org.uk/prep-petition
October 31, 2026 at 9:05 AM
It's the last weekend for you to sign our petition.
Lenacapavir would be a game-changer for those who don't have another PrEP option.
Sign the petition now.
https://tht.org.uk/prep-petition
Lenacapavir would be a game-changer for those who don't have another PrEP option.
Sign the petition now.
https://tht.org.uk/prep-petition
FDA Approves First Generic Of HIV Prevention Drug, Lenacapavir
healthpolicy-watch.news/fda-approves...
healthpolicy-watch.news/fda-approves...
FDA Approves First Generic Of HIV Prevention Drug, Lenacapavir - Health Policy Watch
The US Food and Drug Administration (FDA) has approved the first generic version of lenacapavir, the highly effective twice-yearly injection to prevent HIV,
healthpolicy-watch.news
November 2, 2026 at 6:15 PM
FDA Approves First Generic Of HIV Prevention Drug, Lenacapavir
healthpolicy-watch.news/fda-approves...
healthpolicy-watch.news/fda-approves...
Ohne Tempo, Masse und gerechten Zugang bleibt #Lenacapavir (#LEN) nur aufregende Wissenschaft - mit ihnen kann LEN ein entscheidender Moment für die #HIV- und #Aids- Prävention werden.
#Lenacapavir "Without speed, scale and equity, #LEN is simply exciting science; but, with them, LEN can be a transformational moment in the HIV/AIDS response." @avac.org
avac.org/resource/now...
avac.org/resource/now...
November 2, 2026 at 4:34 PM
Ohne Tempo, Masse und gerechten Zugang bleibt #Lenacapavir (#LEN) nur aufregende Wissenschaft - mit ihnen kann LEN ein entscheidender Moment für die #HIV- und #Aids- Prävention werden.
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV. It's a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV.
bit.ly
November 2, 2026 at 2:16 PM
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV. It's a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
#Lenacapavir "Without speed, scale and equity, #LEN is simply exciting science; but, with them, LEN can be a transformational moment in the HIV/AIDS response." @avac.org
avac.org/resource/now...
avac.org/resource/now...
November 2, 2026 at 4:31 PM
#Lenacapavir "Without speed, scale and equity, #LEN is simply exciting science; but, with them, LEN can be a transformational moment in the HIV/AIDS response." @avac.org
avac.org/resource/now...
avac.org/resource/now...
Decades of NIH-funded research made HIV one of the best-understood viruses ever studied. And in turn, one of the greatest science success stories in our lifetime. THIS is your tax dollars at work.
But, science funding is being dramatically cut, preventing further progress for a HIV vaccine.
But, science funding is being dramatically cut, preventing further progress for a HIV vaccine.
October 31, 2026 at 3:15 PM
Decades of NIH-funded research made HIV one of the best-understood viruses ever studied. And in turn, one of the greatest science success stories in our lifetime. THIS is your tax dollars at work.
But, science funding is being dramatically cut, preventing further progress for a HIV vaccine.
But, science funding is being dramatically cut, preventing further progress for a HIV vaccine.
Big news for #HIVprevention! The US FDA approved the first generic injectable #lenacapavir for #PrEP — an important step in reaching higher volumes @ lower prices as described in our new report, avac.org/resource/now...
November 2, 2026 at 4:01 PM
Big news for #HIVprevention! The US FDA approved the first generic injectable #lenacapavir for #PrEP — an important step in reaching higher volumes @ lower prices as described in our new report, avac.org/resource/now...
#MSF statement on Gilead's Q3 results:
"Gilead continues to rake in huge profits while people worldwide struggle to access #HIV prevention medicine - Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep #lenacapavir out of reach for millions."
"Gilead continues to rake in huge profits while people worldwide struggle to access #HIV prevention medicine - Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep #lenacapavir out of reach for millions."
Gilead continues to rake in huge profits while people worldwide struggle to access HIV prevention medicine
Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep lenacapavir out of reach for millions.
www.doctorswithoutborders.org
October 30, 2026 at 4:00 PM
#MSF statement on Gilead's Q3 results:
"Gilead continues to rake in huge profits while people worldwide struggle to access #HIV prevention medicine - Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep #lenacapavir out of reach for millions."
"Gilead continues to rake in huge profits while people worldwide struggle to access #HIV prevention medicine - Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep #lenacapavir out of reach for millions."
MSF statement here: www.doctorswithoutborders.org/latest/gilea... (4/4)
Gilead continues to rake in huge profits while people worldwide struggle to access HIV prevention medicine
Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep lenacapavir out of reach for millions.
www.doctorswithoutborders.org
October 30, 2026 at 3:18 PM
MSF statement here: www.doctorswithoutborders.org/latest/gilea... (4/4)
👻It’s spooky season, and Gilead is still ghosting MSF. 👻
For more than a year MSF has been trying to buy lenacapavir. We aren’t asking for a donation. We want to pay. Gilead won’t sell to us. We remain confused by this ghoulish refusal.
Gilead's Q3 report just came out. Some spooky facts 🔽(1/4)
For more than a year MSF has been trying to buy lenacapavir. We aren’t asking for a donation. We want to pay. Gilead won’t sell to us. We remain confused by this ghoulish refusal.
Gilead's Q3 report just came out. Some spooky facts 🔽(1/4)
October 30, 2026 at 3:18 PM
👻It’s spooky season, and Gilead is still ghosting MSF. 👻
For more than a year MSF has been trying to buy lenacapavir. We aren’t asking for a donation. We want to pay. Gilead won’t sell to us. We remain confused by this ghoulish refusal.
Gilead's Q3 report just came out. Some spooky facts 🔽(1/4)
For more than a year MSF has been trying to buy lenacapavir. We aren’t asking for a donation. We want to pay. Gilead won’t sell to us. We remain confused by this ghoulish refusal.
Gilead's Q3 report just came out. Some spooky facts 🔽(1/4)
The FDA gave tentative approval to make a generic version of a groundbreaking HIV prevention medicine, a key step in widening access for dozens of low- and middle-income countries. https://www.statnews.com/pharmalot/2026/11/02/lenacapavir-generic-version-approved-fda-hiv-prevention-dr-reddys/
FDA OKs generic HIV prevention shot, widening access for lower-income countries
The FDA has approved a generic HIV prevention shot, a key step in widening access for dozens of lower-income countries.
www.statnews.com
November 2, 2026 at 5:49 PM
The FDA gave tentative approval to make a generic version of a groundbreaking HIV prevention medicine, a key step in widening access for dozens of low- and middle-income countries. https://www.statnews.com/pharmalot/2026/11/02/lenacapavir-generic-version-approved-fda-hiv-prevention-dr-reddys/
Im Rahmen von #HIV- Programmen haben bereits 125.000 Menschen in Afrika mit einer #Lenacapavir- #PrEP zum Schutz vor HIV begonnen. Mit den Generika hofft man, mehrere Millionen Menschen zu erreichen - wofür es aber auch entsprechende Gesundheitssysteme und engagierte Communitys braucht.
November 2, 2026 at 3:54 PM
Im Rahmen von #HIV- Programmen haben bereits 125.000 Menschen in Afrika mit einer #Lenacapavir- #PrEP zum Schutz vor HIV begonnen. Mit den Generika hofft man, mehrere Millionen Menschen zu erreichen - wofür es aber auch entsprechende Gesundheitssysteme und engagierte Communitys braucht.
Unrühmliche Zahlen für Gilead:
>97% der globalen #HIV- Infektionen finden außerhalb der USA statt. Mit der #Lenacapavir- #PrEP (LEN) kann man sich vor HIV-Infektionen schützen. >96% der LEN-Verkäufe finden innerhalb der USA statt. /2
>97% der globalen #HIV- Infektionen finden außerhalb der USA statt. Mit der #Lenacapavir- #PrEP (LEN) kann man sich vor HIV-Infektionen schützen. >96% der LEN-Verkäufe finden innerhalb der USA statt. /2
>97% of new HIV infections happen outside the United States. >96% of LEN sales happen inside it.
In its entire 24 year history, the Global Fund has invested $28.5 billion in HIV programs. Gilead’s HIV sales in the last year and a half come to $37.7 billion. (3/4)
In its entire 24 year history, the Global Fund has invested $28.5 billion in HIV programs. Gilead’s HIV sales in the last year and a half come to $37.7 billion. (3/4)
Gilead continues to rake in huge profits while people worldwide struggle to access HIV prevention medicine
Pharmaceutical corporation made $6.2 billion off HIV products this quarter alone yet continues to keep lenacapavir out of reach for millions.
www.doctorswithoutborders.org
October 30, 2026 at 3:31 PM
Unrühmliche Zahlen für Gilead:
>97% der globalen #HIV- Infektionen finden außerhalb der USA statt. Mit der #Lenacapavir- #PrEP (LEN) kann man sich vor HIV-Infektionen schützen. >96% der LEN-Verkäufe finden innerhalb der USA statt. /2
>97% der globalen #HIV- Infektionen finden außerhalb der USA statt. Mit der #Lenacapavir- #PrEP (LEN) kann man sich vor HIV-Infektionen schützen. >96% der LEN-Verkäufe finden innerhalb der USA statt. /2
Man schätzt, dass die Kosten für die #Lenacapavir- Generika bei etwa 40 US-Dollar pro Jahr liegen werden. In ersten Ländern, darunter Sambia, werden die Generika noch Ende des Jahres 2026 erwartet. Die Zulassung des Generikums erfolgt nur 16 Monate nach Zulassung des Originals zur Prävention.
November 2, 2026 at 3:52 PM
Man schätzt, dass die Kosten für die #Lenacapavir- Generika bei etwa 40 US-Dollar pro Jahr liegen werden. In ersten Ländern, darunter Sambia, werden die Generika noch Ende des Jahres 2026 erwartet. Die Zulassung des Generikums erfolgt nur 16 Monate nach Zulassung des Originals zur Prävention.
Die @taz.de berichtet über die #HIV- Prävention in #Brasilien - und die Anstrengungen der Zivilgesellschaft, die medikamentöse Prophylaxe #PrEP mit #Lenacapavir (2 Spritzen im Jahr) durch Generika erschwinglich zu machen.
HIV-Prophylaxe in Brasilien: Behandeln statt verhandeln
Ein US-Pharmakonzern blockiert den Zugang Hunderttausender Menschen in Brasilien zu einer HIV-Prophylaxe. Wie Lula da Silva das ändern könnte.
taz.de
November 2, 2026 at 4:20 PM
Die @taz.de berichtet über die #HIV- Prävention in #Brasilien - und die Anstrengungen der Zivilgesellschaft, die medikamentöse Prophylaxe #PrEP mit #Lenacapavir (2 Spritzen im Jahr) durch Generika erschwinglich zu machen.
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
https://triblive.com/news/world/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countries/
https://triblive.com/news/world/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countries/
November 2, 2026 at 5:19 PM
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
https://triblive.com/news/world/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countries/
https://triblive.com/news/world/approval-of-a-cheap-version-of-hiv-prevention-shot-lenacapavir-raises-hopes-in-low-income-countries/
📢 Lenacapavir could be a game-changer for #HIV prevention, but right now it is not being made available as PrEP.
With 18 other HIV organisations, we’ve written to NHS England, NHS Wales, NICE, and Gilead Sciences to call for action: https://ow.ly/4uhI5101P1G
With 18 other HIV organisations, we’ve written to NHS England, NHS Wales, NICE, and Gilead Sciences to call for action: https://ow.ly/4uhI5101P1G
October 28, 2026 at 5:32 PM
📢 Lenacapavir could be a game-changer for #HIV prevention, but right now it is not being made available as PrEP.
With 18 other HIV organisations, we’ve written to NHS England, NHS Wales, NICE, and Gilead Sciences to call for action: https://ow.ly/4uhI5101P1G
With 18 other HIV organisations, we’ve written to NHS England, NHS Wales, NICE, and Gilead Sciences to call for action: https://ow.ly/4uhI5101P1G
The South African government has introduced lenacapavir, a HIV prevention drug. Thousands have started on the injections, but questions about future costs and supplies will need to be resolved to ensure the campaign’s success, write Katherine Bliss and Priya Chainani.
Read: https://bit.ly/4BoQzjC
Read: https://bit.ly/4BoQzjC
Sustaining South Africa’s Progress in the Next Phase of the HIV Fight
South Africa has 8 million people living with HIV, and the government has introduced lenacapavir, a new HIV prevention drug. Thousands have started on the injections, but questions about future costs ...
bit.ly
October 28, 2026 at 8:00 PM
The South African government has introduced lenacapavir, a HIV prevention drug. Thousands have started on the injections, but questions about future costs and supplies will need to be resolved to ensure the campaign’s success, write Katherine Bliss and Priya Chainani.
Read: https://bit.ly/4BoQzjC
Read: https://bit.ly/4BoQzjC
